Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

Tyrosine kinase inhibitors (TKI) have revolutionized the treatment of chronic myeloid leukemia (CML), but patients still experience treatment‐limiting toxicities or therapeutic failure. To investigate the real‐world use and outcomes of imatinib in patients with CML in Australia, a retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Adattini, Josephine A., Gross, Annette S., Wong Doo, Nicole, McLachlan, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475133/
https://www.ncbi.nlm.nih.gov/pubmed/36106342
http://dx.doi.org/10.1002/prp2.1005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475133/
https://www.ncbi.nlm.nih.gov/pubmed/36106342
http://dx.doi.org/10.1002/prp2.1005

Ejemplares similares